Clinical trials recruiting for Non Alcoholic Steatohepatitis

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
  NCT04690972 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
  NCT07099118 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
  NCT05623150 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
  NCT06138821 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
  NCT06569524 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 53 locations
• Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease
  NCT05728697 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
  NCT04190849 · Phase: Not specified · Ages: Up to 18 Years · Sex: All (male and female) · 3 locations
• Identification of Liver Fibrosis Biomarkers
  NCT06819917 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
  NCT05463796 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Integrated Diagnostics for Early Diagnosis of Liver Disease
  NCT04666402 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
  NCT03884075 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Prognostic Significance of Fatty Liver Disease in Bariatric Patients
  NCT03535142 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Soluble Fibre Supplementation in NAFLD
  NCT05480696 · Phase: Phase 2 · Ages: 8 Years to 17 Years · Sex: All (male and female) · 1 location
• Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
  NCT05821010 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Olmsted NAFLD Epidemiology Study (TONES)
  NCT04365855 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Non Alcoholic Steatohepatitis often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Non Alcoholic Steatohepatitis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.